Anti-body R&D company Escugen closes Pre-A raising tens of millions in RMB

On August 24, Shanghai Shijian Biotechnology Co., Ltd., or Escugen announced the completion of its Pre-A round of financing worth tens of millions of yuan.

2020-08-27
|
Lynn Lin

JD Xintonglu covers more than 300 cities in China

On August 24, Zheng Hongyan, Vice President of JD.com Group and President of the JD.com’s Xintonglu Department that was in charge of the omni-channel retail business, announced that the JD Xintonglu would upgrade its cooperation with the supermarkets...

2020-08-27
|
Lynn Lin

Two former executives of Baidu.com join Bytedance

Recently, Wu Haifeng and Sun Wenyu, two of the five executives who had quitted Baidu out of the blue in May last year, have joined Bytedance.

2020-08-27
|
Lynn Lin

Dongfeng Motor plans to deploy more than 200 Robotaxi in Wuhan

On August 25, Dongfeng Company announced that it will join forces with WeRide.ai, Deeproute.ai, UISEE, AutoX and other autonomous driving companies to establish the country’s largest autonomous driving network in the Wuhan Development Zone.

2020-08-26
|
Michael Liang

360 Finance's Q2 revenue increased by 50.3% year-on-year

Data show that 360 Finance's revenue in the second quarter was 3.34 billion yuan, a year-on-year increase of 50.3%.

2020-08-24
|
ChinaFinance

Guangdong to ban non-degradable plastic tableware by end of 2020

Recently, the official website of the Guangdong Provincial Development and Reform Commission issued the Implementation Opinions on Further Strengthening the Control of Plastic Pollution.

2020-08-24
|
GreenChina

Phase III clinical trial of China's covid-19 inactivated vaccine launched in Argentina

The world’s first inactivated COVID-19 vaccine developed and produced by Sinopharm Group’s China National Biotec Group (CNBG) was approved by the National Food, Drugs and Medical Technology Administration (ANMAT) under the Ministry of Health of...

2020-08-24
|
ChinaMedical

China's first COVID-19 vaccine produced by insect cells obtained clinical trial approval

The recombinant protein COVID-19 vaccine developed by a key laboratory of biological therapy of West China Hospital of Sichuan University was approved by the State Drug Administration for clinical trials, according to Jiemian.com.


Shanghai will continue to build global asset management center: official

Shanghai will make every effort to create a world-class financial development environment, further strengthen the function of global resource allocation, and further connect the domestic and international double markets in a strategic way, a local...


China started emergency use of Covid-19 vaccine on July 22

China has officially launched the emergency use of the Covid-19 vaccine on July 22, Zheng Zhongwei, an official of the National Health Commission, said on CCTV's Dialogue program.

2020-08-23
|
Roy Li

Jack Ma decreases shareholding in Ant Group's employee shareholding entity

On August 21, Hangzhou Yunbo Investment Consulting Co., Ltd., as Ant Group's employee shareholding entity, had an industrial and commercial change, with Jack Ma's shareholding in the company dropping from 100% to 34%, Tianyancha App showed.

2020-08-23
|
Roy Li

D2M Biotherapeutics completes $10 million Pre-A round of financing

D2M Biotherapeutics, a tumor immunological drug developer, recently completed a Pre-A round of US$10 million in financing led by Apricot Capital (Shanghai).

2020-08-23
|
ChinaPEVC

World's first new energy UHV transmission channel starts operation

As of the 21st, the world's first large UHV power transmission channel mainly for the transmission of new energy, which is called Qinghai-Henan ±800 kV UHV DC Project, has delivered 1 billion kwh of green power to Henan, with an average daily power...


China Securities ranks first in underwriting sponsorship revenue this year

As of August 23, 244 companies have completed IPOs and listed publicly this year, with a total initial fundraising total of 289.748 billion yuan. Both the number of IPOs and the actual fundraising scale have exceeded that of last year.

2020-08-23
|
ChinaFinance

Yitu Tech business scope adds medical equipment sales and value-added telecommunications services

Shanghai Yitu Network Technology (Yitu Tech) has undergone many industrial and commercial changes recently, according to Tianyancha APP.

China SDG